9-65283380-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001126334.1(FOXD4L5):c.998G>A(p.Gly333Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001126334.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00 AC: 3AN: 149170Hom.: 0 Cov.: 21 FAILED QC
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000137 AC: 20AN: 1459682Hom.: 0 Cov.: 40 AF XY: 0.0000110 AC XY: 8AN XY: 726146
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000201 AC: 3AN: 149276Hom.: 0 Cov.: 21 AF XY: 0.0000413 AC XY: 3AN XY: 72654
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.998G>A (p.G333E) alteration is located in exon 1 (coding exon 1) of the FOXD4L5 gene. This alteration results from a G to A substitution at nucleotide position 998, causing the glycine (G) at amino acid position 333 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at